Heartbeam Inc
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-… Read more
Heartbeam Inc (BEAT) - Total Liabilities
Latest total liabilities as of September 2025: $2.47 Million USD
Based on the latest financial reports, Heartbeam Inc (BEAT) has total liabilities worth $2.47 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Heartbeam Inc - Total Liabilities Trend (2003–2024)
This chart illustrates how Heartbeam Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Heartbeam Inc Competitors by Total Liabilities
The table below lists competitors of Heartbeam Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Seronics Co. Ltd
KQ:042600
|
Korea | ₩118.34 Billion |
|
Alicon Castalloy Limited
NSE:ALICON
|
India | ₹7.09 Billion |
|
Cho Kwang Leat
KO:004700
|
Korea | ₩77.74 Billion |
|
FORTEC Elektronik AG
F:FEV
|
Germany | €18.79 Million |
|
PetMed Express Inc
NASDAQ:PETS
|
USA | $55.20 Million |
|
Heran Co Ltd
TW:5283
|
Taiwan | NT$3.23 Billion |
|
PT Wintermar Offshore Marine Tbk
F:W6O
|
Germany | €49.91 Million |
|
Bcl Industries Limited
NSE:BCLIND
|
India | ₹7.94 Billion |
Liability Composition Analysis (2003–2024)
This chart breaks down Heartbeam Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 6.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.86 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Heartbeam Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Heartbeam Inc (2003–2024)
The table below shows the annual total liabilities of Heartbeam Inc from 2003 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.62 Million | +35.85% |
| 2023-12-31 | $1.19 Million | -28.29% |
| 2022-12-31 | $1.67 Million | +183.16% |
| 2021-12-31 | $588.00K | -87.84% |
| 2020-12-31 | $4.84 Million | +29.51% |
| 2019-12-31 | $3.73 Million | -98.65% |
| 2018-12-31 | $276.32 Million | +0.53% |
| 2017-12-31 | $274.86 Million | +357.56% |
| 2016-12-31 | $60.07 Million | +24.58% |
| 2015-12-31 | $48.22 Million | -21.09% |
| 2014-12-31 | $61.10 Million | +194.94% |
| 2013-12-31 | $20.72 Million | +3.52% |
| 2012-12-31 | $20.01 Million | +17.87% |
| 2011-12-31 | $16.98 Million | -21.99% |
| 2010-12-31 | $21.76 Million | +14.73% |
| 2009-12-31 | $18.97 Million | +21.16% |
| 2008-12-31 | $15.66 Million | -87.95% |
| 2007-12-31 | $129.90 Million | +250.84% |
| 2006-12-31 | $37.03 Million | +44.83% |
| 2004-12-31 | $25.57 Million | +80.66% |
| 2003-12-31 | $14.15 Million | -- |